Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis-Reference-Cited by-同舟云学术

Purinergic signalling at the plasma membrane: a multipurpose and multidirectional mode to deal with amyotrophic lateral sclerosis and multiple sclerosis

Published:2011-01-07 Issue:5 Volume:116 Page:796-805
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:

Author:

Amadio Susanna,Apolloni Savina,D’Ambrosi Nadia,Volonté Cinzia

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1471-4159.2010.07025.x/fullpdf

Reference81 articles.

1. Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development;Agresti;Glia,2005

2. Mechanism of action of IFN-beta in the treatment of multiple sclerosis: a special reference to CD73 and adenosine;Airas;Ann. N Y Acad. Sci.,2007

3. Ca(21) influx through AMPA or kainate receptors alone is sufficient to initiate excitotoxicity in cultured oligodendrocytes;Alberdi;Neurobiol. Dis.,2002

4. P2Y12 receptor protein in cortical gray matter lesions in multiple sclerosis;Amadio;Cereb. Cortex,2010

5. Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis;Andries;Neurobiol. Dis.,2007

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TAAR1 Regulates Purinergic-induced TNF Secretion from Peripheral, But Not CNS-resident, Macrophages;Journal of Neuroimmune Pharmacology;2022-11-16

2. Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection;Molecular Neurobiology;2021-07-11

3. P2X7 Receptor Upregulation in Huntington’s Disease Brains;Frontiers in Molecular Neuroscience;2020-10-06

4. ATP release during seizures – A critical evaluation of the evidence;Brain Research Bulletin;2019-09

5. Purinergic implication in amyotrophic lateral sclerosis—from pathological mechanisms to therapeutic perspectives;Purinergic Signalling;2018-11-14